Parteck® M DPI is a synthetic and versatile carrier option for your dry powder inhalation (DPI) formulation. Engineered from mannitol, Parteck® M DPI particles are designed to improve the flow and release characteristics of active pharmaceutical ingredients (APIs) in drugs delivered via dry, inhaled powders.
No reducing sugars, no incompatibility issues.
Reducing sugars are a major threat to the stability of small molecule APIs with primary amine groups. Lactose is one such reducing sugar. Mannitol, another non-reducing sugar alternative, in general still contains trace levels of reducing sugar impurities of up to 0.10% according to pharmacopeia. In contrast, Parteck® M DPI is designed to limit impurities to a maximum level of 0.05%, as granted by the CoA specification. Actual values are typically even lower.
Other benefits of our Parteck® M DPI: